Novel nanopore protein mutants of hfab and their use in sequencing
Novel nanoporin mutants with targeted mutations and modifications address the limitations of existing nanopore sequencing by enhancing pore stability and accuracy, providing improved sequencing signals and reduced noise.
Patent Information
- Authority / Receiving Office
- HK · HK
- Patent Type
- Applications
- Current Assignee / Owner
- BEIJING POLYSEQ BIOTECH CO LTD
- Filing Date
- 2026-05-14
- Publication Date
- 2026-07-17
AI Technical Summary
Current nanopore sequencing technologies face challenges with scarce suitable nanoporins, poor sequencing signals, and low accuracy due to inadequate pore stability, key amino acid composition, and pore diameter range in nanopore walls.
Development of novel nanoporin mutants with specific mutations and modifications at critical positions, including deletions and additions of amino acids, to enhance pore stability and sequencing accuracy, using recombinant expression vectors in host cells like Escherichia coli.
The novel nanoporin mutants exhibit improved sequencing current properties, increased signal amplitude, reduced spontaneous blockage, and enhanced accuracy, offering more options for nanopore sequencing with stable pore currents.
Smart Images

Figure 00000000_0000_ABST